drug users

Summary

Summary: People who take drugs for a non-therapeutic or non-medical effect. The drugs may be legal or illegal, but their use often results in adverse medical, legal, or social consequences for the users.

Top Publications

  1. Khazaee Pool M, Arefi Z, Roshani D, Pashaei T, Ponnet K. Development and psychometric properties of a questionnaire to measure drug users' attitudes toward methadone maintenance treatment (DUAMMT) in Iran. BMC Public Health. 2017;17:906 pubmed publisher
    Assessing drug users' attitudes towards different kinds of addiction treatment is necessary to design tailored strategies...
  2. Meader N, Li R, Des Jarlais D, Pilling S. Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users. Cochrane Database Syst Rev. 2010;:CD007192 pubmed publisher
    b>Drug users (including both injection drug users and crack cocaine users), are at high levels of risk for contracting HIV...
  3. Boettiger D, Law M, Dore G, Guy R, Callander D, Donovan B, et al. Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance data. BMC Infect Dis. 2017;17:740 pubmed publisher
    ..Continued monitoring of HCV incidence in this population is essential for guiding both HCV prevention and treatment strategies. ..
  4. Grebely J, Haire B, Taylor L, Macneill P, Litwin A, Swan T, et al. Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data?. J Hepatol. 2015;63:779-82 pubmed publisher
  5. Reece S. Dental health in addiction. Aust Dent J. 2009;54:185-6 pubmed publisher
  6. Webster L. Risk Factors for Opioid-Use Disorder and Overdose. Anesth Analg. 2017;125:1741-1748 pubmed publisher
    ..Clinical tools and an evolving evidence base are available to assist clinicians with identifying patients whose risk factors put them at risk for adverse outcomes with opioids. ..
  7. Antonio N, Diehl A, Niel M, Pillon S, Ratto L, Pinheiro M, et al. Sexual addiction in drug addicts: The impact of drug of choice and poly-addiction. Rev Assoc Med Bras (1992). 2017;63:414-421 pubmed publisher
    ..0012), but not in the alcohol group. Our study reinforces the importance of assessing sexual behavior of drug addicts in clinical practice, especially considering users of multiple substances or with severe dependence. ..
  8. Sun F, Long A, Yu P, Huang H, Chiang C, Yao Y. Category 3 and 4 Controlled Drugs Users' Perceptions of Participating in Drug-Abuse-Health Prevention Lectures in Taiwan. Arch Psychiatr Nurs. 2017;31:338-344 pubmed publisher
    This study was designed to explore Category 3 and 4 controlled drug users' perceptions of participating in health-prevention lectures. A phenomenological approach was used...
  9. Belaunzarán Zamudio P, Mosqueda Gómez J, Macias Hernandez A, Sierra Madero J, Ahmed S, Beyrer C. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico. PLoS ONE. 2017;12:e0179931 pubmed publisher
    ..HCV diagnostic and treatment services, and harm-reduction programs for incarcerated injecting-drug users in Mexico should be integrated to control the HCV epidemic in Mexico.

More Information

Publications32

  1. Moreno G, Wang A, Sanchez Gonzalez Y, Diaz Espinosa O, Vania D, Edlin B, et al. Value of Comprehensive HCV Treatment among Vulnerable, High-Risk Populations. Value Health. 2017;20:736-744 pubmed publisher
  2. Akiyama M, Agyemang L, Arnsten J, Heo M, Norton B, Schackman B, et al. Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy. BMC Infect Dis. 2018;18:74 pubmed publisher
    ..outlined here can serve as a template for the development of future programs and studies among HCV-infected drug users receiving opioid agonist therapy, as well as the cost-effectiveness of such programs...
  3. Nolan S, Buxton J, Dobrer S, Dong H, Hayashi K, Milloy M, et al. Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015. Public Health Rep. 2017;132:563-569 pubmed publisher
    ..53; P < .001), and at least daily heroin injection (aOR = 1.69; 95% CI, 1.09-2.62; P < .02). Efforts to improve knowledge of and participation in the THN program may contribute to reduced opioid overdose mortality in Vancouver. ..
  4. Horyniak D, Dietze P, Lenton S, Alati R, Bruno R, Matthews A, et al. Trends in reports of driving following illicit drug consumption among regular drug users in Australia, 2007-2013: Has random roadside drug testing had a deterrent effect?. Accid Anal Prev. 2017;104:146-155 pubmed publisher
    ..We examined trends over time in self-reported past six-month drug-driving among sentinel samples of regular drug users and assessed the impact of experiences of RDT on drug-driving among these participants...
  5. Kelly J, Wakeman S, Saitz R. Stop talking 'dirty': clinicians, language, and quality of care for the leading cause of preventable death in the United States. Am J Med. 2015;128:8-9 pubmed publisher
  6. Kazatchkine M. Russia's ban on methadone for drug users in Crimea will worsen the HIV/AIDS epidemic and risk public health. BMJ. 2014;348:g3118 pubmed publisher
  7. Richardson L, Sherman S, Kerr T. Employment amongst people who use drugs: a new arena for research and intervention?. Int J Drug Policy. 2012;23:3-5 pubmed publisher
  8. Mboi N. Indonesia. A consummate insider pushes ideas from outside Indonesia. Science. 2014;345:162-3 pubmed publisher
  9. Tirpack A, Duker J, Baumal C. An Outbreak of Endogenous Fungal Endophthalmitis Among Intravenous Drug Abusers in New England. JAMA Ophthalmol. 2017;135:534-540 pubmed publisher
    ..Reporting significant increases in heroin-related deaths since 2014, the New England region is in the midst of an opioid crisis that has led to a substantial increase in patients at risk for this vision-threatening disease...
  10. Burki T. Russia's drug policy fuels infectious disease epidemics. Lancet Infect Dis. 2012;12:275-6 pubmed
  11. Mor Z, Dan M. The HIV epidemic among men who have sex with men--behaviour beats science. EMBO Rep. 2012;13:948-53 pubmed publisher
  12. Paraschiv S, Banica L, Nicolae I, Niculescu I, Abagiu A, Jipa R, et al. Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users. PLoS ONE. 2017;12:e0185866 pubmed publisher
    ..65%) and associated with an outbreak among PWID during detention in the same penitentiary. This study has reconstructed and compared the dispersion of these two viruses in a PWID population...
  13. Ghany M, Strader D, Thomas D, Seeff L. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49:1335-74 pubmed publisher
  14. Fischer B, Cruz M, Bastos F, Tyndall M. Crack across the Americas - a massive problem in continued search of viable answers: exemplary views from the North (Canada) and the South (Brazil). Int J Drug Policy. 2013;24:631-3 pubmed publisher
  15. Zhou K, Wang D, Li H, Wei X, Yin J, Liang P, et al. Bidirectional relationships between retention and health-related quality of life in Chinese mainland patients receiving methadone maintenance treatment. PLoS ONE. 2017;12:e0179009 pubmed publisher
    ..In conclusion, retention and HRQoL tended to have a bidirectional relationship, which should be considered in the development of retention and health-management programs for patients with MMT. ..
  16. Ballantyne J. Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, and Future Directions. Anesth Analg. 2017;125:1769-1778 pubmed publisher
    ..The focus of this article is on what we have learned since opioid treatment of chronic pain was first popularized at the end of the 20th century and how this new information can guide chronic pain management in the future...
  17. Armstrong G, Nuken A, Samson L, Singh S, Jorm A, Kermode M. Quality of life, depression, anxiety and suicidal ideation among men who inject drugs in Delhi, India. BMC Psychiatry. 2013;13:151 pubmed publisher
    ..The mean length of injecting career was 20.9 years indicating a sample of chronic injecting drug users, of whom only one-third (38%) were born in Delhi...
  18. Corbacho A, Rivera M, Trujillo F, Martí M, Carbonell J, Fernandez F, et al. A perspective from drug user organisations on 'ECDC and EMCDDA guidance: prevention and control of infectious diseases among people who inject drugs'. BMC Infect Dis. 2014;14 Suppl 6:S10 pubmed publisher
  19. Shariatirad S, Maarefvand M, Ekhtiari H. Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran. Int J Drug Policy. 2013;24:e115-6 pubmed publisher
  20. Feehan D, Umubyeyi A, Mahy M, Hladik W, Salganik M. Quantity Versus Quality: A Survey Experiment to Improve the Network Scale-up Method. Am J Epidemiol. 2016;183:747-57 pubmed publisher
    ..Our design can be customized and extended for other settings, enabling researchers to continue to improve the network scale-up method. ..
  21. El Bassel N, Strathdee S, El Sadr W. HIV and people who use drugs in central Asia: confronting the perfect storm. Drug Alcohol Depend. 2013;132 Suppl 1:S2-6 pubmed publisher
  22. Bernard C, Owens D, Goldhaber Fiebert J, Brandeau M. Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis. PLoS Med. 2017;14:e1002312 pubmed publisher
  23. Ferguson L, Batey R. Prisons, prisoners, and hepatitis C. J Gastroenterol Hepatol. 2010;25:1184-6 pubmed publisher